ID   NALM-29
AC   CVCL_5667
SY   NALM29
DR   Cosmic; 999744
DR   Cosmic; 1037717
DR   JCRB; JCRB1854
DR   Wikidata; Q54907411
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=9680106;
RX   PubMed=10456671;
RX   PubMed=10576511;
RX   PubMed=10637496;
CC   Population: Japanese.
CC   Doubling time: 46 hours (PubMed=10456671).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 1 fused to ABL1 exon 2 (e1a2 transcript) (PubMed=10576511).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): JCRB=JCRB1854
ST   Amelogenin: X,Y
ST   CSF1PO: 10,13
ST   D13S317: 9,12
ST   D16S539: 9,11
ST   D5S818: 9,12
ST   D7S820: 10,12
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 14,17
DI   NCIt; C114819; Adult B acute lymphoblastic leukemia with t(9;22)(q34.1;q11.2) BCR-ABL1
DI   ORDO; Orphanet_585909; B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_QX02 ! B391
SX   Male
AG   46Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 16
//
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RA   Drexler H.G.;
RT   "The leukemia-lymphoma cell line factsbook.";
RL   (In book) ISBN 9780122219702; pp.1-733; Academic Press; London; United Kingdom (2001).
//
RX   PubMed=9680106; DOI=10.1016/S0145-2126(98)00050-2;
RA   Matsuo Y., Drexler H.G.;
RT   "Establishment and characterization of human B cell precursor-leukemia
RT   cell lines.";
RL   Leuk. Res. 22:567-579(1998).
//
RX   PubMed=10456671; DOI=10.1016/S0145-2126(99)00086-7;
RA   Matsuo Y., Drexler H.G., Takeuchi M., Orita K.;
RT   "A novel biphenotypic B-cell precursor leukemia cell line (NALM-29)
RT   carrying t(9;22)(q34;q11) established from a patient with acute
RT   leukemia.";
RL   Leuk. Res. 23:731-740(1999).
//
RX   PubMed=10576511; DOI=10.1016/S0145-2126(99)00131-9;
RA   Uphoff C.C., Habig S., Fombonne S., Matsuo Y., Drexler H.G.;
RT   "ABL-BCR expression in BCR-ABL-positive human leukemia cell lines.";
RL   Leuk. Res. 23:1055-1060(1999).
//
RX   PubMed=10637496; DOI=10.1038/sj.leu.2401604;
RA   Drexler H.G., Fombonne S., Matsuo Y., Hu Z.-B., Hamaguchi H.,
RA   Uphoff C.C.;
RT   "p53 alterations in human leukemia-lymphoma cell lines: in
RT   vitro artifact or prerequisite for cell immortalization?";
RL   Leukemia 14:198-206(2000).
//